Kura Oncology (KURA) Return on Assets (QoQ) (2011 - 2026)

Kura Oncology (KURA) Return on Assets (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn
7 Belite Bio 63.46 Bn 63.46 Bn -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn
10 Kura Oncology 930.41 Mn 930.41 Mn 18.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Sep 30, 2015 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 2.00
Sep 30, 2014 2.00
Jun 30, 2014 -1.00
Mar 31, 2014 -1.00
Dec 31, 2013 -1.00
Sep 30, 2013 1.00
Jun 30, 2013 2.00
Mar 31, 2013 -2.00
Dec 31, 2012 -1.00
Sep 30, 2012 -1.00
Jun 30, 2012 0.00